Loss-of-function alleles ofP2RX7andTLR4fail to affect the response to chemotherapy in non-small cell lung cancer
Open Access
- 1 May 2012
- journal article
- research article
- Published by Taylor & Francis in OncoImmunology
- Vol. 1 (3) , 271-278
Abstract
The success of anticancer chemotherapy relies at least in part on the induction of an immune response against tumor cells. Thus, tumors growing on mice that lack the pattern recognition receptor TL...Keywords
This publication has 46 references indexed in Scilit:
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of IdoNature Medicine, 2011
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumorsNature Medicine, 2011
- Immune parameters affecting the efficacy of chemotherapeutic regimensNature Reviews Clinical Oncology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic DeathCancer Research, 2010
- Evidence for associations between the purinergic receptor P2X7 (P2RX7) and toxoplasmosisGenes & Immunity, 2010
- Immunogenic and tolerogenic cell deathNature Reviews Immunology, 2009
- Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell deathThe EMBO Journal, 2009
- The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapyImmunological Reviews, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007